Annual report
6315.TEDINET S100W53I
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥53.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥50.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥53.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥29.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.9bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥8.7bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥9.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥9.1bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.2bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.7bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥11.2bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥9.1bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.4bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.3bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥8.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥6.4bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥83.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥87.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥73.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥71.3bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥51.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥21.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥29.4bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥61.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥58.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥47.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥41.1bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥31.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥21.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥20.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.4bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥10.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥108.28 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.9 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.9 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.36 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.5 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥818.41 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥779.18 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥629.13 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥542.86 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥415.6 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.1% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 13.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.6% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,099 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,985 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,876 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 1,817 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,633 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥41.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥41.7bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥42.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥42.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.9bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥4.3bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥3.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.9bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥3.7bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥3.4bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥52.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥60.0bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥50.6bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥51.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥38.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥17.6bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥24.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥35.5bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥29.2bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥22.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥48.73 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.18 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.71 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.93 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.67 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥466.62 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥473.55 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥389.04 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥360.21 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥299.73 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 66.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 75,140,556 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,043,888 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,033,238 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,021,832 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 25,021,832 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 681 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 623 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 597 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 573 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 549 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Devicereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥184m |
| Medical Devicereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥134m |
| Medical Devicereportable segment | employees | at 2025-03-31 | 87 pure |
| Medical Devicereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Medical Devicereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| Medical Devicereportable segment | segment assets | at 2025-03-31 | ¥3.1bn |
| Medical Devicereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥453m |
| Semiconductor Equipmentreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| Semiconductor Equipmentreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥2.4bn |
| Semiconductor Equipmentreportable segment | employees | at 2025-03-31 | 1906 pure |
| Semiconductor Equipmentreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥49.0bn |
| Semiconductor Equipmentreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥49.0bn |
| Semiconductor Equipmentreportable segment | segment assets | at 2025-03-31 | ¥78.3bn |
| Semiconductor Equipmentreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥8.4bn |
| Medical Devicereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥275m |
| Medical Devicereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥111m |
| Medical Devicereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.2bn |
| Medical Devicereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.2bn |
| Medical Devicereportable segment | segment assets | at 2024-03-31 | ¥2.7bn |
| Medical Devicereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥458m |
| Semiconductor Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Semiconductor Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2.3bn |
| Semiconductor Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥45.9bn |
| Semiconductor Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥45.9bn |
| Semiconductor Equipmentreportable segment | segment assets | at 2024-03-31 | ¥83.4bn |
| Semiconductor Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥8.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,630
| Item | Context | Value | Unit |
|---|---|---|---|
| Retirement benefit expenses sga | Prior1YearDuration | 88580000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 63162000 | JPY |
| Provision for share based remuneration sga | Prior1YearDuration | 14235000 | JPY |
| Provision for share based remuneration sga | CurrentYearDuration | 14426000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 764496000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 1154838000 | JPY |
| Commission fee sga | Prior1YearDuration | 1119321000 | JPY |
| Commission fee sga | CurrentYearDuration | 1208662000 | JPY |
| Research and development expenses included in general and administrative expenses | Prior1YearDuration | 963200000 | JPY |
| Research and development expenses included in general and administrative expenses | CurrentYearDuration | 1393476000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 45903845000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2150867000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 2417087000 | JPY |
| Revenues from external customers | Prior1YearDuration | 50471799000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 45903845000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2150867000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 2417087000 | JPY |
| Net sales | Prior1YearDuration | 50471799000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 8097933000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 458335000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 105560000 | JPY |
| Operating income | Prior1YearDuration | 8661829000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 83366305000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2709307000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 1786220000 | JPY |
| Assets | Prior1YearInstant | 87861833000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 2347829000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 111341000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 50061000 | JPY |
| Depreciation segment information | Prior1YearDuration | 2509233000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 146567000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration | 146567000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 1665669000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 275317000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 63364000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration | 2004351000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | 48959043000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | 2263915000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | 2256247000 | JPY |
| Revenues from external customers | CurrentYearDuration | 53479205000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E01708-000SemiconductorEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E01708-000MedicalDeviceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E01708-000LaserProcessingMachinesMember | － | JPY |
| Transactions with other segments | CurrentYearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |